1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Agreement among double-blind reports
Concordant Readings (CI 95%) Class 2 Discrepancies Class 1 Discrepancies
Clinically pertinent findings 75.6% (n = 90) (67.2%–82.5%) 15.1% (n = 18) 9.2% (n = 11)
Incidental findings 65.5% (n = 78) (56.6%–73.5%) 29.4% (n = 35) 5% (n = 6)
Answer to the clinician's question 86.7% (n = 85) (78%–92.5%) 12.2% (n = 12) 1% (n = 1)
Further investigations 86.6% (n = 103) (79.2%–91.6%) 13.4% (n = 16)

	Concordant Readings (CI 95%)	Class 2 Discrepancies	Class 1 Discrepancies
Clinically pertinent findings	75.6% (n = 90) (67.2%–82.5%)	15.1% (n = 18)	9.2% (n = 11)
Incidental findings	65.5% (n = 78) (56.6%–73.5%)	29.4% (n = 35)	5% (n = 6)
Answer to the clinician's question	86.7% (n = 85) (78%–92.5%)	12.2% (n = 12)	1% (n = 1)
Further investigations	86.6% (n = 103) (79.2%–91.6%)	13.4% (n = 16)